However, drinking alcohol may affect blood sugar levels, making Ozempic less effective
Microdosing semaglutide suppresses appetite more slowly and gradually compared to standard doses
Retatrutide is an investigational research compound that is not FDA approved
Due to risks for decreased bioavailability of birth control pills, the manufacturer of Mounjaro (tirzepatide) recommends that patients either use barrier contraception for four weeks after initiation or dosage increase or switch to a non-oral contraceptive
Retatrutide Peptide is an investigational medication being studied for conditions related to metabolism, especially body weight regulation and blood sugar control
Rybelsus is typically initiated at 3 mg daily for one month, then increased to 7 mg, with a possible further increase to 14 mg if additional glycaemic control is needed